📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-04 16:41
24 analysed today
24
Today
133,666
All-time analysed
40,136
Positive
6,284
Negative
79,424
Neutral
7,754
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
3 announcements match the current filters (relevance ≥ 5).
Rs 15.01 Cr Fundraise: Grovy India Allots 41.69 Lakh Shares at Rs 36/Share
Grovy India has completed a preferential allotment of 41.69 lakh equity shares, raising approximately Rs 15.01 crore. The issue price of Rs 36 per share represents a significant discount to the current market price of Rs 53.2. This capital infusion is substantial for the company, representing roughly 21% of its current market capitalization and 65% of its existing net worth. The allotment includes participation from both the promoter group (approx 40% of the issue) and 15 public investors.
Confidence: HIGH
What changedThe company has issued 41.69 lakh new equity shares to promoters and public investors, increasing its total share count and raising Rs 15.01 Cr in cash.
Why it mattersFor a micro-cap company with a Rs 71 Cr market cap, a Rs 15 Cr infusion provides significant liquidity to either reduce debt or fund project execution, potentially improving its 10.2% ROCE.
Total Fundraise Amount: Rs 15.01 CrIssue Price per Share: Rs 36Fundraise vs Market Cap: ~21.1%Fundraise vs Net Worth: ~65.3%Equity Dilution: ~23.8%
📅 Short termThe stock may face pressure due to the equity dilution and the fact that the issue price is at a ~32% discount to the current market price, though the capital infusion is fundamentally positive.
📈 Long termIf the management effectively utilizes the Rs 15 Cr to scale its residential and commercial portfolio, it could lead to a structural improvement in revenue growth and debt management.
⚠ Risk flags
- Significant equity dilution of approximately 23.8%
- Issue price is substantially lower than the current market price
Key Highlights
Allotment of 41,69,433 equity shares at an issue price of Rs 36 per share
Total aggregate amount raised is Rs 15,00,99,588 (Rs 15.01 Cr)
Promoter group subscribed to 16,66,664 shares, roughly 40% of the total allotment
Post-allotment paid-up equity capital increased to Rs 17.51 Cr (1,75,05,705 shares)
Fundraise magnitude is approximately 65% of the company's reported net worth of Rs 23 Cr
👀 What to Watch
Investors should monitor the company's next quarterly results to see how the cash infusion impacts the debt-to-equity ratio (currently 1.08) and if the funds are deployed into new residential or commercial projects.
Grovy India Q1 Revenue Up 249% QoQ; Plans ₹40 Cr Fundraise and NSE Listing
Grovy India reported a strong sequential recovery in Q1 FY27, with revenue surging 249.40% QoQ to ₹27.58 Cr and PAT rising 114.02% to ₹1.90 Cr. The company is executing a ₹40 Cr capital raising initiative, with ₹15 Cr already in progress via a preferential issue of 41.69 lakh shares. Management has set an aggressive target to scale execution to 20-25 projects annually over the next three years, up from its current base. Additionally, the company has commenced three projects with Golden Growth Fund and aims for an NSE listing within three years.
Confidence: HIGH
What changedThe company has transitioned from a low-volume period to an aggressive growth phase, backed by a management reshuffle and a significant capital-raising plan.
Why it mattersThe ₹40 Cr fundraise is substantial, representing approximately 56% of the current market cap, which is intended to fuel a 2-3x expansion in project volume in the high-margin South Delhi market.
Q1 FY27 Revenue: ₹27.58 CrQoQ Revenue Growth: 249.40%Planned Fundraise: ₹40 CrFundraise vs Market Cap: 56.3%Annual Project Target: 20-25 unitsQ1 FY27 EPS: ₹1.43
📅 Short termThe sharp sequential growth in earnings and the immediate ₹15 Cr fundraise are likely to support positive sentiment in the coming weeks.
📈 Long termThe company's shift toward a higher-volume redevelopment model and the goal of an NSE listing suggest a structural attempt to re-rate the business from a micro-cap to a mid-scale developer.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Equity dilution from the preferential issue of 41.69 lakh shares
- High Debt-to-Equity ratio of 1.08
- Geographic concentration risk in South Delhi
Key Highlights
Revenue grew 249.40% QoQ to ₹27.58 Cr in Q1 FY27 compared to ₹7.89 Cr in Q4 FY26
Profit After Tax (PAT) increased 114.02% QoQ to ₹1.90 Cr from ₹0.89 Cr
Raising ₹15 Cr in July 2026 as part of a total ₹40 Cr fundraise approved by shareholders
Targeting a 2-3x increase in project development through collaborations like the Golden Growth Fund
Aims to scale execution to 20-25 projects annually over the next 3 years
👀 What to Watch
Investors should monitor the allotment of the preferential shares in July-August 2026 and the execution timeline of the three new projects with Golden Growth Fund to validate the 20-25 annual project target.
Grovy India Submits Q1 FY27 Financial Results for Quarter Ended June 30, 2026
Grovy India has filed its unaudited financial results for the quarter ended June 30, 2026, in compliance with SEBI regulations. The company, a small-cap real estate player with a market capitalization of ₹71 Cr, reported a TTM revenue of ₹33 Cr and a PAT of ₹3 Cr prior to this filing. Investors should evaluate these results against the previous year's Q1 (June 2025) performance, which saw revenue of ₹8.25 Cr and a net profit of ₹1.1 Cr. The filing includes the mandatory Limited Review Report from the auditors.
Confidence: MEDIUM
What changedThe company has formally reported its financial performance for the first quarter of the 2026-27 fiscal year.
Why it mattersFor a micro-cap company with ₹33 Cr TTM revenue, quarterly results are vital to track project execution and cash flow needed to service its ₹25 Cr debt.
Quarter ended: 30th June 2026TTM Revenue: ₹33 CrDebt-to-Equity: 1.08Promoter Holding: 73.0%Market Cap: ₹71 Cr
📅 Short termThe stock price may react to the specific growth or contraction in net profit compared to the ₹0.89 Cr reported in the preceding March 2026 quarter.
📈 Long termLimited structural change unless the results demonstrate a significant scale-up in project deliveries beyond the current ₹33 Cr annual revenue run rate.
⚠ Risk flags
- High Debt-to-Equity ratio (1.08)
- Small-cap liquidity risk
- Concentration in residential/commercial real estate projects
Key Highlights
Submission of unaudited financial results for the quarter ended June 30, 2026
Compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Includes Limited Review Report for the period ending June 2026
Company maintains a high promoter holding of 73.0% as of the latest reporting cycle
TTM revenue stands at ₹33 Cr with an operating profit margin of 7.9%
👀 What to Watch
Investors should examine the full P&L statement to see if revenue exceeded the ₹8.25 Cr mark from the same quarter last year and monitor the debt-to-equity ratio, which was 1.08.
